Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Properties of human glycine receptors containing the hyperekplexia mutation alpha1(K276E), expressed in Xenopus oocytes.
Lewis TM, Sivilotti LG, Colquhoun D, Gardiner RM, Schoepfer R, Rees M.
???displayArticle.abstract???
1. Inherited defects in human glycine receptors give rise to hyperekplexia (startle disease). We expressed human glycine receptors in Xenopus oocytes, in order to examine the pharmacological and single-channel properties of receptors that contain a mutation, alpha1(K276E), associated with an atypical form of hyperekplexia. 2. Equilibrium concentration-response curves showed that recombinant human alpha1(K276E)beta receptors had a 29-fold lower glycine sensitivity than wild-type alpha1beta receptors, and a greatly reduced Hill coefficient. The maximum response to glycine also appeared much reduced, whereas the equilibrium constant for the glycine receptor antagonist strychnine was unchanged. 3. Both wild-type and mutant channels opened to multiple conductance levels with similar main conductance levels (33 pS) and weighted mean conductances (41.5 versus 49.8 pS, respectively). 4. Channel openings were shorter for the alpha1(K276E)beta mutant than for the wild-type alpha1beta, with mean overall apparent open times of 0.82 and 6.85 ms, respectively. 5. The main effect of the alpha1(K276E) mutation is to impair the opening of the channel rather than the binding of glycine. This is shown by the results of fitting glycine dose-response curves with particular postulated mechanisms, the shorter open times of mutant channels, the properties of single-channel bursts, and the lack of an effect of the mutation on the strychnine-binding site.
ARUNLAKSHANA,
Some quantitative uses of drug antagonists.
1959, Pubmed
ARUNLAKSHANA,
Some quantitative uses of drug antagonists.
1959,
Pubmed Baxter,
Co-dominant inheritance of hyperekplexia and spastic paraparesis.
1996,
Pubmed Bormann,
Residues within transmembrane segment M2 determine chloride conductance of glycine receptor homo- and hetero-oligomers.
1993,
Pubmed Brune,
A GLRA1 null mutation in recessive hyperekplexia challenges the functional role of glycine receptors.
1996,
Pubmed Campos-Caro,
A single residue in the M2-M3 loop is a major determinant of coupling between binding and gating in neuronal nicotinic receptors.
1996,
Pubmed
,
Xenbase Colquhoun,
Fast events in single-channel currents activated by acetylcholine and its analogues at the frog muscle end-plate.
1985,
Pubmed Colquhoun,
Molecular pharmacology. The binding issue.
1993,
Pubmed Edmonds,
Mechanisms of activation of muscle nicotinic acetylcholine receptors and the time course of endplate currents.
1995,
Pubmed Elmslie,
Analysis of GLRA1 in hereditary and sporadic hyperekplexia: a novel mutation in a family cosegregating for hyperekplexia and spastic paraparesis.
1996,
Pubmed Grenningloh,
Alpha subunit variants of the human glycine receptor: primary structures, functional expression and chromosomal localization of the corresponding genes.
1990,
Pubmed
,
Xenbase Handford,
The human glycine receptor beta subunit: primary structure, functional characterisation and chromosomal localisation of the human and murine genes.
1996,
Pubmed Krieg,
Functional messenger RNAs are produced by SP6 in vitro transcription of cloned cDNAs.
1984,
Pubmed
,
Xenbase Kuhse,
Assembly of the inhibitory glycine receptor: identification of amino acid sequence motifs governing subunit stoichiometry.
1993,
Pubmed
,
Xenbase Kurczynski,
Hyperekplexia.
1983,
Pubmed Kusama,
Mutagenesis of the GABA rho 1 receptor alters agonist affinity and channel gating.
1994,
Pubmed
,
Xenbase Langosch,
Conserved quaternary structure of ligand-gated ion channels: the postsynaptic glycine receptor is a pentamer.
1988,
Pubmed Langosch,
Decreased agonist affinity and chloride conductance of mutant glycine receptors associated with human hereditary hyperekplexia.
1994,
Pubmed
,
Xenbase Lynch,
Mutations affecting the glycine receptor agonist transduction mechanism convert the competitive antagonist, picrotoxin, into an allosteric potentiator.
1995,
Pubmed Lynch,
Identification of intracellular and extracellular domains mediating signal transduction in the inhibitory glycine receptor chloride channel.
1997,
Pubmed Malosio,
Widespread expression of glycine receptor subunit mRNAs in the adult and developing rat brain.
1991,
Pubmed Maxwell,
Colocalization of glycine and GABA in synapses on spinomedullary neurons.
1995,
Pubmed MONOD,
ON THE NATURE OF ALLOSTERIC TRANSITIONS: A PLAUSIBLE MODEL.
1965,
Pubmed Nigro,
Hyperekplexia and sudden neonatal death.
1992,
Pubmed Pribilla,
The atypical M2 segment of the beta subunit confers picrotoxinin resistance to inhibitory glycine receptor channels.
1992,
Pubmed Rajendra,
Molecular mechanisms of inherited startle syndromes.
1995,
Pubmed Rajendra,
Mutation of an arginine residue in the human glycine receptor transforms beta-alanine and taurine from agonists into competitive antagonists.
1995,
Pubmed Rajendra,
Startle disease mutations reduce the agonist sensitivity of the human inhibitory glycine receptor.
1994,
Pubmed Rees,
Evidence for recessive as well as dominant forms of startle disease (hyperekplexia) caused by mutations in the alpha 1 subunit of the inhibitory glycine receptor.
1994,
Pubmed Ruiz-Gómez,
Localization of the strychnine binding site on the 48-kilodalton subunit of the glycine receptor.
1990,
Pubmed Ryan,
Startle disease, or hyperekplexia: response to clonazepam and assignment of the gene (STHE) to chromosome 5q by linkage analysis.
1992,
Pubmed SCHILD,
pAx and competitive drug antagonism.
1949,
Pubmed Schorderet,
An additional family with Startle disease and a G1192A mutation at the alpha 1 subunit of the inhibitory glycine receptor gene.
1994,
Pubmed Shiang,
Mutational analysis of familial and sporadic hyperekplexia.
1995,
Pubmed Shiang,
Mutations in the alpha 1 subunit of the inhibitory glycine receptor cause the dominant neurologic disorder, hyperekplexia.
1993,
Pubmed Sigworth,
Data transformations for improved display and fitting of single-channel dwell time histograms.
1987,
Pubmed Takahashi,
Functional correlation of fetal and adult forms of glycine receptors with developmental changes in inhibitory synaptic receptor channels.
1992,
Pubmed
,
Xenbase Todd,
Colocalization of GABA, glycine, and their receptors at synapses in the rat spinal cord.
1996,
Pubmed Triller,
gamma-Aminobutyric acid-containing terminals can be apposed to glycine receptors at central synapses.
1987,
Pubmed Twyman,
Kinetic properties of the glycine receptor main- and sub-conductance states of mouse spinal cord neurones in culture.
1991,
Pubmed Unwin,
Acetylcholine receptor channel imaged in the open state.
1995,
Pubmed Vandenberg,
Antagonism of ligand-gated ion channel receptors: two domains of the glycine receptor alpha subunit form the strychnine-binding site.
1992,
Pubmed Vigevano,
Startle disease: an avoidable cause of sudden infant death.
1989,
Pubmed Watanabe,
Distribution patterns of mRNAs encoding glycine receptor channels in the developing rat spinal cord.
1995,
Pubmed
